Antineurofilament antibodies in postpolio syndrome

V. E. Drory*, A. Shapira, A. D. Korczyn, S. Shavit, M. Kushnir, D. M. Michaelson, J. Chapman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We determined the levels of antineurofilament antibodies in 29 patients with postpolio syndrome (PPS), 26 stable postpolio (PP) patients, 22 patients with ALS, and 20 normal controls (NCs). Patients with PPS had higher antibody levels to cholinergic neurofilaments than did all other groups. PP patients and those with ALS had antibody levels similar to those of NCs. The antibody binding level showed no relation to the age of the patients, duration of disease, or motor score.

Original languageEnglish
Pages (from-to)1193-1195
Number of pages3
Issue number4
StatePublished - Oct 1998


Dive into the research topics of 'Antineurofilament antibodies in postpolio syndrome'. Together they form a unique fingerprint.

Cite this